Liposomal Formulations Enhance the Anti-Inflammatory Effect of Eicosapentaenoic Acid in HL60 Cells

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2022 Mar 26

PMID 35335896

Authors

Puneet Kaur

Jin Gao

Zhenjia Wang

Affiliations

Soon will be listed here.

Abstract

Dietary omega 3 polyunsaturated fatty acids (PUFAs), including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), have been reported to be beneficial for cardiovascular diseases and cancer. Such diseases share a common pathophysiological feature of inflammation responses, such as unbalanced oxidative stress and increased cytokine release. PUFAs show anti-inflammatory effects, and thus, they are potential therapeutics to treat inflammatory disorders. Here, we proposed a novel liposomal formulation of EPA (EPA-liposomes), and the liposome was PEGylated to increase their stability. In the study, we measured the physicochemical characteristics of EPA-liposomes and their anti-inflammatory effects in neutrophil-like cells (HL 60 cells). The results showed that EPA-liposomes dramatically decreased the production of NO, ROS, and cytokines compared to EPA alone, and the molecular mechanism is associated with biosynthesis of RvE1 from EPA, and RvE1 binds to GPCRs to mediate the anti-inflammatory effects.

Citing Articles

Mechanisms of HIV-immunologic non-responses and research trends based on gut microbiota.

Sun X, Xie Z, Wu Z, Song M, Zhang Y, Zhang Z Front Immunol. 2025; 15():1378431.

PMID: 39802299 PMC: 11718445. DOI: 10.3389/fimmu.2024.1378431.

Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner.

Gao J, Su Y, Wang Z Pharmaceutics. 2023; 15(5).

PMID: 37242769 PMC: 10221144. DOI: 10.3390/pharmaceutics15051527.

References

von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H . The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999; 130(7):554-62. DOI: 10.7326/0003-4819-130-7-199904060-00003. View

Dakin S, Colas R, Wheway K, Watkins B, Appleton L, Rees J . Proresolving Mediators LXB4 and RvE1 Regulate Inflammation in Stromal Cells from Patients with Shoulder Tendon Tears. Am J Pathol. 2019; 189(11):2258-2268. PMC: 6876268. DOI: 10.1016/j.ajpath.2019.07.011. View

Vas Dias F, Gibney M, Taylor T . The effect of polyunsaturated fatty acids on the n-3 and n-6 series on platelet aggregation and platelet and aortic fatty acid composition in rabbits. Atherosclerosis. 1982; 43(2-3):245-57. DOI: 10.1016/0021-9150(82)90026-0. View

Gao J, Dong X, Wang Z . Generation, purification and engineering of extracellular vesicles and their biomedical applications. Methods. 2019; 177:114-125. PMC: 7198327. DOI: 10.1016/j.ymeth.2019.11.012. View

Gao J, Wang S, Wang Z . High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy. Biomaterials. 2017; 135:62-73. PMC: 5516786. DOI: 10.1016/j.biomaterials.2017.05.003. View

Hosseini H, Ghorbani M, Jafari S, Sadeghi Mahoonak A . Encapsulation of EPA and DHA concentrate from fish oil by milk proteins and evaluation of its oxidative stability. J Food Sci Technol. 2019; 56(1):59-70. PMC: 6342774. DOI: 10.1007/s13197-018-3455-9. View

Wright H, Moots R, Bucknall R, Edwards S . Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford). 2010; 49(9):1618-31. DOI: 10.1093/rheumatology/keq045. View

Alaarg A, Jordan N, Verhoef J, Metselaar J, Storm G, Kok R . Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment. Int J Nanomedicine. 2016; 11:5027-5040. PMC: 5063558. DOI: 10.2147/IJN.S115995. View

Siddiquee A, Patel M, Rajalingam S, Narke D, Kurade M, Ponnoth D . Effect of omega-3 fatty acid supplementation on resolvin (RvE1)-mediated suppression of inflammation in a mouse model of asthma. Immunopharmacol Immunotoxicol. 2019; 41(2):250-257. DOI: 10.1080/08923973.2019.1584903. View

10.

Wang H, Liu M, Weng S, Li J, Xie C, He H . Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J Gastroenterol. 2012; 18(2):119-25. PMC: 3257438. DOI: 10.3748/wjg.v18.i2.119. View

11.

Ohira T, Arita M, Omori K, Recchiuti A, Van Dyke T, Serhan C . Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J Biol Chem. 2009; 285(5):3451-61. PMC: 2823415. DOI: 10.1074/jbc.M109.044131. View

12.

Duvall M, Levy B . DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation. Eur J Pharmacol. 2015; 785:144-155. PMC: 4854800. DOI: 10.1016/j.ejphar.2015.11.001. View

13.

Wang S, Dong X, Gao J, Wang Z . Targeting Inflammatory Vasculature by Extracellular Vesicles. AAPS J. 2018; 20(2):37. PMC: 6288379. DOI: 10.1208/s12248-018-0200-2. View

14.

Sercombe L, Veerati T, Moheimani F, Wu S, Sood A, Hua S . Advances and Challenges of Liposome Assisted Drug Delivery. Front Pharmacol. 2015; 6:286. PMC: 4664963. DOI: 10.3389/fphar.2015.00286. View

15.

Dong X, Gao J, Zhang C, Hayworth C, Frank M, Wang Z . Neutrophil Membrane-Derived Nanovesicles Alleviate Inflammation To Protect Mouse Brain Injury from Ischemic Stroke. ACS Nano. 2019; 13(2):1272-1283. PMC: 6424134. DOI: 10.1021/acsnano.8b06572. View

16.

Serhan C, Chiang N . Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol. 2013; 13(4):632-40. PMC: 3732499. DOI: 10.1016/j.coph.2013.05.012. View

17.

Werner M, Jordan P, Romp E, Czapka A, Rao Z, Kretzer C . Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome. FASEB J. 2019; 33(5):6140-6153. PMC: 6988863. DOI: 10.1096/fj.201802509R. View

18.

Gao L, Faibish D, Fredman G, Herrera B, Chiang N, Serhan C . Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. J Immunol. 2012; 190(2):689-94. PMC: 3538964. DOI: 10.4049/jimmunol.1103688. View

19.

Kelley W, Fromen C, Lopez-Cazares G, Eniola-Adefeso O . PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils. Acta Biomater. 2018; 79:283-293. PMC: 6181144. DOI: 10.1016/j.actbio.2018.09.001. View

20.

Gao J, Dong X, Su Y, Wang Z . Human neutrophil membrane-derived nanovesicles as a drug delivery platform for improved therapy of infectious diseases. Acta Biomater. 2021; 123:354-363. PMC: 7920994. DOI: 10.1016/j.actbio.2021.01.020. View